Analysis of relapse rates in pegylated interferon and ribavirin non-responders treated with daily consensus interferon and ribavirin

被引：0
|
作者：
Hassanein, Tarek
Ghalib, Reem H.
Zein, Nizar N.
Rothstein, Kenneth D.
Joshi, Shobha N.
Kwo, Paul Yien
Hammond, Janet
机构：
[1] Univ Calif San Diego, Ctr Liver, San Diego, CA 92103 USA
[2] Methodist Hosp, Liver Inst, Dallas, TX USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Albert Einstein Ctr Liver Dis, Philadelphia, PA USA
[5] Tulane Univ, New Orleans, LA 70118 USA
[6] Indiana Univ, Indianapolis, IN 46204 USA
[7] Valeant Pharmaceut N Amer, Aliso Viejo, CA USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1319
引用
收藏
页码：824A / 824A
页数：1
相关论文
共 50 条
  • [1] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
  • [2] Triple therapy (interferon, ribavirin, amantadine) for non-responders of combination therapy with interferon and ribavirin?.
    Thuluvath, PJ
    Maygers, J
    HEPATOLOGY, 2000, 32 (04) : 557A - 557A
  • [3] Efficacy of daily consensus interferon and ribavirin compared to PEG-interferon α-2b and ribavirin in non-responders with chronic Hepatitis C
    Dollinger, MM
    Dridi, Y
    Lesske, J
    Behl, S
    Fleig, WE
    HEPATOLOGY, 2005, 42 (04) : 691A - 692A
  • [4] The direct trial (daily-dose consensus interferon and ribavirin: efficacy of combined therapy): Treatment of non-responders to previous pegylated interferon plus ribavirin: Sustained virologic response data
    Bacon, Bruce
    Regev, Arie
    Ghalib, Reem H.
    Morelli, Giuseppe
    Rothstein, Kenneth D.
    Shiffman, Mitchell L.
    Hossanein, Tarek
    Hammond, Janet
    HEPATOLOGY, 2007, 46 (04) : 311A - 312A
  • [5] Early Virological Response with Consensus Interferon and Ribavirin in HCV Genotype 3 Non-Responders and Relapsers to Pegylated Interferon Based Therapy
    Shakir, Tanzila
    Abbas, Zaigham
    Memon, Sadik
    Tayyab, Ghias
    Shaikh, Kashif
    Nasir, Bilal
    Hassan, Ghias
    Subhan, Amna
    Hamid, Saeed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S122 - S123
  • [6] COMPARISON OF ROLLOVER VS WASHOUT DAILY INTERFERON ALFACON-1 AND RIBAVIRIN IN THE RETREATMENT OF NON-RESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN FOR HEPATITIS C VIRUS INFECTION
    Fahmy, Marianne
    Gabbert, Charles
    Richards, Lisa
    Andrews, Barbara G.
    Kuo, Alexander
    HEPATOLOGY, 2010, 52 (04) : 814A - 815A
  • [7] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Goncales, Fernando L., Jr.
    Moma, Camila A.
    Vigani, Aline G.
    Angerami, Adriana F. C. F.
    Goncales, Eduardo S. L.
    Tozzo, Raquel
    Pavan, Maria H. P.
    Goncales, Neiva S. L.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [8] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
  • [9] Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin
    Stauber, R
    Munda-Steindl, P
    Hackl, F
    Schüutze, K
    Datz, C
    Hofer, H
    Hegenbarth, K
    Jessner, W
    Ferenci, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 134 - 135
  • [10] Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant α-interferon
    Bresci, G
    Parisi, G
    Bertoni, M
    Scatena, F
    Capria, A
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (01) : 75 - 78
12345